Clearmind Medicine Inc.

CMND chart

Clearmind Medicine Inc. news

• A 25,300-share holder reports a below-5% stake in Clearmind Medicine (CMND).

  Stock Titan · Oct 27, 9:33 PM EDT

• Clearmind completes patient recruitment for AUD trial segment By Investing.com

  Investing.com India · Oct 27, 8:42 AM EDT

• Clearmind Medicine Completes Recruitment for First Part B Cohort in Phase I/IIa Trial of CMND-100 for Alcohol Use Disorder

  Quiver Quantitative · Oct 27, 8:30 AM EDT

• Clearmind Successfully Completes Patient Recruitment for the First Alcohol Use Disorder Cohort of its CMND-100 Phase I/IIa Clinical Trial

  Yahoo Finance · Oct 27, 8:22 AM EDT

• Clearmind Medicine Inc. Estimates – NASDAQ:CMND

  TradingView · Oct 23, 7:45 AM EDT

• How Much Downside Is Left In Moderna Stock?

  trefis.com · Oct 23, 4:00 AM EDT

• What Is The Case For Waiting On Moderna Stock?

  trefis.com · Oct 16, 10:44 AM EDT

• Where Could Moderna's Next Growth Come From?

  trefis.com · Oct 12, 5:01 PM EDT

• Weekly Roundup on the Cannabis Sector & Psychedelic Sector

  Yahoo Finance · Oct 12, 10:29 AM EDT

• Clearmind: Charging Robotics Launches Next-Generation Automated EV-Charging Technology for Robotaxis and Autonomous Fleets

  Yahoo Finance · Oct 12, 7:55 AM EDT

• Clearmind Announces Patent Publication in Japan Covering Treatment for Neurological Movement Disorder

  Yahoo Finance · Oct 8, 7:32 AM EDT

• Clearmind Advances Dialogue with U.S. Federal Government on Psychedelic Therapies, Submitting Recommendations to FDA

  Yahoo Finance · Oct 7, 8:40 AM EDT

Clearmind Medicine Inc. key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-27
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-16
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-13
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-08
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-07
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-30
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-23
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-17
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-14
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-10
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-08
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-04

About Clearmind Medicine Inc.

Ticker

CMND (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Vancouver, British Columbia, Canada (Federal Level)

Incorporated in

Canada (Federal Level)

Fiscal year end

October 31

SEC CIK

1892500

Frequently asked questions